![Susan Badia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan Badia
Vorstandsvorsitzender bei Xgen Pharmaceuticals DJB, Inc.
Profil
Susan Badia currently works at Xgen Pharmaceuticals DJB, Inc., as President & Chief Executive Officer from 2003, The Food & Drug Law Institute, as Member, and Association for Accessible Medicines, as Member.
Ms. Badia received her graduate degree in 1990 from Pepperdine University.
Aktive Positionen von Susan Badia
Unternehmen | Position | Beginn |
---|---|---|
Xgen Pharmaceuticals DJB, Inc.
![]() Xgen Pharmaceuticals DJB, Inc. Pharmaceuticals: MajorHealth Technology Xgen Pharmaceuticals DJB, Inc.. develops and manufactures pharmaceutical products. It offers injectables, anti-infective solutions, oral solids, powders for prescription compounding and inhalants. The company was founded by Dan J. badia in 2003 and is headquartered in Horseheads, NY. | Vorstandsvorsitzender | 01.06.2003 |
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Corporate Officer/Principal | 13.04.2009 |
The Food & Drug Law Institute
![]() The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022. | Corporate Officer/Principal | 13.04.2009 |
Ausbildung von Susan Badia
Pepperdine University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Xgen Pharmaceuticals DJB, Inc.
![]() Xgen Pharmaceuticals DJB, Inc. Pharmaceuticals: MajorHealth Technology Xgen Pharmaceuticals DJB, Inc.. develops and manufactures pharmaceutical products. It offers injectables, anti-infective solutions, oral solids, powders for prescription compounding and inhalants. The company was founded by Dan J. badia in 2003 and is headquartered in Horseheads, NY. | Health Technology |
Association for Accessible Medicines
![]() Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
The Food & Drug Law Institute
![]() The Food & Drug Law Institute Miscellaneous Commercial ServicesCommercial Services The Food & Drug Law Institute is a nonprofit membership organization that provides education, training, publications, and professional engagement opportunities in the field of food and drug law. The non-profit company is based in Washington. The American company offers a platform for stakeholders to inform innovative public policy, law, and regulation. Christine M. Simmon has been the CEO of the company since 2022. | Commercial Services |